BusundR., LindsetmoR.O., RassmussenL.T.. Tumor necrosis factor and interleukin 1 appearance in experimental Gram-negative septic shick. The effect of plasma exchange with albumin and plasma infusion.Arch Surg1991; 126: 591–7.
2.
DöckeW.D., SyrbeU., MeineckeA.. Improvement of monocyte function - a new therapeutic approach? In: ReinhartK., EyrichK., SpringC.. (Hrsg). Sepsis - Current perspectives in pathophysiology and therapy.Berlin: Springer, 1994; 473–500.
JanbonB., VuillezJ.P., CarpentierF.. Removal of circulating tumor necrosis factor. Its role in septic shock treatment.Ann Med Interne Paris1992; 143: 13–6.
5.
KhaitovR.M., GalperinEl, PodobinN.P.. Extracorporeal immunopharmacotherapy in patients with chronic septic cholangitis.Hepatogastroenterology1990; 40: 126–30.
6.
NatansonC., HoffmanW.D., Danner. A controlled trial of plasmapheresis (P) fails to improve outcome in an antibiotic treated canine model of human septic shock (SS).Crit Care Med1989; 17: S57.
7.
PollackM.. Blood exchange and plasmapheresis in sepsis and septic shock.Clin Inf Dis1992; 15: 431–3.
8.
RokkeO., RasmussenL., GierckskyK.E.. The influence of plasma exchange on shock mediators in septicemia.Surg Res Com1990; 8: 173–82.
9.
ScharfmanW.B., TillotsonJ.R., TaftE.G., WrightE.. Plasmapheresis for menigococcemia with disseminated intravascular coagulation.N Engl J Med1979; 10: 1277.
10.
Van DeurenM., SantmanF.W., van DalenR.. Plasma and whole blood exchange in meningococcal sepsis.Clin Infect Dis1992; 15: 424–30.
11.
WestendorpR.G.J., BrandtA., ThompsonJ., DikH., MeindersA.E.. Experiences with plasma- and leucapheresis in meningococcal septicaemia.Intensive Care Med1990; 16: S102.
